NasdaqGS - Delayed Quote USD
Blueprint Medicines Corporation (BPMC)
127.60
-0.19
(-0.15%)
At close: 4:00:02 PM EDT
127.62
+0.02
+(0.02%)
After hours: 6:12:12 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 183,208 | 18 |
| Sales | 146,914 | 29 |
| Net Shares Purchased (Sold) | 36,294 | 47 |
| Total Insider Shares Held | 560.57k | -- |
| % Net Shares Purchased (Sold) | 6.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ALBERS JEFFREY W Director | Conversion of Exercise of derivative security at price 36.05 per share. | Direct | 180,250 | May 27, 2025 |
| ALBERS JEFFREY W Director | Sale at price 101.02 - 101.93 per share. | Direct | 505,692 | May 27, 2025 |
| ROSSI CHRISTINA Chief Operating Officer | Sale at price 100.14 - 101.72 per share. | Direct | 228,557 | May 19, 2025 |
| HURLEY ARIEL Officer | Conversion of Exercise of derivative security at price 54.13 per share. | Direct | 148,966 | May 5, 2025 |
| ROSSI CHRISTINA Chief Operating Officer | Sale at price 100.97 - 103.56 per share. | Direct | 231,386 | May 5, 2025 |
| HURLEY ARIEL Officer | Sale at price 102.51 - 104.78 per share. | Direct | 283,819 | May 5, 2025 |
| HAVILAND KATE Chief Executive Officer | Sale at price 85.47 - 88.59 per share. | Direct | 216,461 | Apr 1, 2025 |
| ROSSI CHRISTINA Chief Operating Officer | Sale at price 95.02 per share. | Direct | 216,075 | Mar 24, 2025 |
| ALBERS JEFFREY W Director | Conversion of Exercise of derivative security at price 36.05 per share. | Direct | 270,375 | Mar 12, 2025 |
| ALBERS JEFFREY W Director | Sale at price 87.62 - 88.37 per share. | Direct | 658,500 | Mar 12, 2025 |
| HEWES LEMUEL BECKER Officer | Sale at price 87.42 - 88.80 per share. | Direct | 890,639 | Mar 6, 2025 |
| ALBERS JEFFREY W Director | Sale at price 88.80 per share. | Direct | 512,021 | Mar 5, 2025 |
| LANDSITTEL MICHAEL Chief Financial Officer | Sale at price 88.80 per share. | Direct | 469,219 | Mar 5, 2025 |
| ROSSI CHRISTINA Chief Operating Officer | Sale at price 88.80 per share. | Direct | 576,756 | Mar 5, 2025 |
| HURLEY ARIEL Officer | Sale at price 88.80 per share. | Direct | 117,749 | Mar 5, 2025 |
| MCCAIN TRACEY LORENE Officer | Sale at price 88.80 per share. | Direct | 467,266 | Mar 5, 2025 |
| DURSO-BUMPUS DEBRA Officer | Sale at price 88.80 per share. | Direct | 457,942 | Mar 5, 2025 |
| NAMOUNI FOUAD Officer | Sale at price 88.80 per share. | Direct | 576,223 | Mar 5, 2025 |
| LEE PHILINA Officer | Sale at price 88.80 per share. | Direct | 331,490 | Mar 5, 2025 |
| CARTER PERCY H Officer | Sale at price 88.80 per share. | Direct | 313,464 | Mar 5, 2025 |
| HAVILAND KATE Chief Executive Officer | Sale at price 88.80 per share. | Direct | 1,434,209 | Mar 5, 2025 |
| HURLEY ARIEL Officer | Sale at price 89.63 - 95.16 per share. | Direct | 296,666 | Mar 3, 2025 |
| LANDSITTEL MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| MCCAIN TRACEY LORENE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| ROSSI CHRISTINA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HURLEY ARIEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| DURSO-BUMPUS DEBRA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| NAMOUNI FOUAD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HEWES LEMUEL BECKER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| LEE PHILINA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| CARTER PERCY H Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| HAVILAND KATE Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| ROSSI CHRISTINA Chief Operating Officer | Sale at price 95.14 per share. | Direct | 216,348 | Feb 20, 2025 |
| ALBERS JEFFREY W Director | Conversion of Exercise of derivative security at price 36.05 per share. | Direct | 360,500 | Jan 21, 2025 |
| ALBERS JEFFREY W Director | Sale at price 109.11 - 110.61 per share. | Direct | 1,660,511 | Jan 21, 2025 |
| ROSSI CHRISTINA Chief Operating Officer | Sale at price 108.99 - 111.81 per share. | Direct | 250,455 | Jan 21, 2025 |
| HAVILAND KATE Chief Executive Officer | Sale at price 110.24 per share. | Direct | 159,407 | Jan 21, 2025 |
| ALBERS JEFFREY W Director | Conversion of Exercise of derivative security at price 36.05 per share. | Direct | 180,250 | Jan 13, 2025 |
| HURLEY ARIEL Officer | Conversion of Exercise of derivative security at price 36.05 per share. | Direct | 81,112 | Jan 13, 2025 |
| ALBERS JEFFREY W Director | Sale at price 102.28 per share. | Direct | 511,400 | Jan 13, 2025 |
| HURLEY ARIEL Officer | Sale at price 100.00 per share. | Direct | 225,000 | Jan 13, 2025 |
| ALBERS JEFFREY W Director | Conversion of Exercise of derivative security at price 36.05 per share. | Direct | 540,750 | Dec 19, 2024 |
| ALBERS JEFFREY W Director | Sale at price 88.28 - 91.96 per share. | Direct | 1,346,615 | Dec 19, 2024 |
| ROSSI CHRISTINA Chief Operating Officer | Sale at price 95.88 - 96.50 per share. | Direct | 218,098 | Dec 18, 2024 |
| HURLEY ARIEL Officer | Conversion of Exercise of derivative security at price 15.01 per share. | Direct | 24,016 | Dec 12, 2024 |
| HURLEY ARIEL Officer | Sale at price 92.88 - 93.99 per share. | Direct | 169,636 | Dec 12, 2024 |
| HAVILAND KATE Chief Executive Officer | Sale at price 95.40 - 97.76 per share. | Direct | 227,304 | Nov 29, 2024 |
| ROSSI CHRISTINA Chief Operating Officer | Sale at price 95.10 per share. | Direct | 216,257 | Nov 27, 2024 |
| COATS LONNEL Director | Sale at price 93.15 - 94.99 per share. | Direct | 1,869,658 | Nov 21, 2024 |
| COATS LONNEL Director | Conversion of Exercise of derivative security at price 69.79 - 76.24 per share. | Direct | 623,452 | Nov 20, 2024 |
Related Tickers
KYMR Kymera Therapeutics, Inc.
43.58
+1.04%
VERA Vera Therapeutics, Inc.
30.91
-2.61%
LYRA Lyra Therapeutics, Inc.
27.58
+36.20%
LYEL Lyell Immunopharma, Inc.
7.99
-2.80%
SMMT Summit Therapeutics Inc.
20.62
+16.33%
BNTX BioNTech SE
115.64
+2.25%
RCKT Rocket Pharmaceuticals, Inc.
2.9600
+6.86%
MRUS Merus N.V.
62.42
+6.65%
NTLA Intellia Therapeutics, Inc.
7.69
+7.40%
SPRO Spero Therapeutics, Inc.
2.6400
-3.65%